Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (416)	4/26/1999 12:08:00 PM
From: LLCF	Read Replies (1) \| Respond to of 712

George, if you can get ahold of MTSL or CTSL's reasoning on this one it seems rather compelling to me. The idea is advantages of integrelin over CNTO's repro and MRK's whatever it is....I know these guys (esp. CTSL) have a rather miserable track record.. but who doesn't in biotech. I think you could take like 1/2 of MTSL picks and do great. Personally I'm surprised that CORR is being so aggressive in sales forecasts, as they seem to have been conservative in the past. Do you know the exact deal they have with Shering-Plough?? DAK